$1.74 Billion is the total value of Sofinnova Investments, Inc.'s 67 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CALA | Exit | Calithera Biosciences Inc | $0 | – | -757,533 | -100.0% | -0.11% | – |
| PBYI | Exit | Puma Biotechnology Inc | $0 | – | -344,917 | -100.0% | -0.20% | – |
| Exit | Heron Therapeutics Inccall | $0 | – | -250,000 | -100.0% | -0.24% | – | |
| Exit | Aptose Biosciences Inc | $0 | – | -696,928 | -100.0% | -0.25% | – | |
| ARNA | Exit | Arena Pharmaceuticals Inc | $0 | – | -91,448 | -100.0% | -0.38% | – |
| SNDX | Exit | Syndax Pharmaceuticals Inc | $0 | – | -298,644 | -100.0% | -0.40% | – |
| Exit | ChemoCentryx Incput | $0 | – | -150,000 | -100.0% | -0.46% | – | |
| ATHA | Exit | Athira Pharma, Inc. | $0 | – | -509,168 | -100.0% | -0.56% | – |
| HZNP | Exit | Horizon Therapeutics PLC | $0 | – | -133,997 | -100.0% | -0.74% | – |
| Exit | Gilead Sciences Inccall | $0 | – | -300,000 | -100.0% | -1.17% | – | |
| MRUS | Exit | Merus N.V. | $0 | – | -1,311,039 | -100.0% | -1.65% | – |
| LLY | Exit | Eli Lilly and Co | $0 | – | -180,501 | -100.0% | -2.03% | – |
| JAZZ | Exit | Jazz Pharmaceuticals PLC | $0 | – | -255,928 | -100.0% | -2.53% | – |
| Exit | Health Care Select Sector SPDRput | $0 | – | -400,000 | -100.0% | -2.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Natera, Inc. | 23 | Q3 2023 | 20.5% |
| Ascendis Pharma A/S | 23 | Q3 2023 | 27.9% |
| NuCana plc | 23 | Q3 2023 | 15.2% |
| Synlogic Inc. (fmrly Mirna) | 22 | Q2 2023 | 0.9% |
| Y-mAbs Therapeutics, Inc. | 21 | Q3 2023 | 6.5% |
| ObsEva SA | 20 | Q4 2022 | 11.0% |
| Nucana PLC | 19 | Q3 2023 | 9.7% |
| SYNDAX PHARMACEUTICALS INC | 19 | Q3 2023 | 2.2% |
| PDS Biotechnology Corporation | 19 | Q3 2023 | 0.1% |
| Karuna Therapeutics, Inc. | 18 | Q3 2023 | 27.1% |
View Sofinnova Investments, Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| OTONOMY, INC.Sold out | February 14, 2022 | 0 | 0.0% |
View Sofinnova Investments, Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View Sofinnova Investments, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.